Treatment of Granulomas in Patients With Ataxia Telangiectasia.

Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.

Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.

Secondary enuresis and urological manifestations in children with ataxia telangiectasia.

P 111 - Rehabilitation results in children with ataxia telengiectasia: three case reports.

Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.

B-cell subsets imbalance and reduced expression of CD40 in ataxia-telangiectasia patients.

A novel variant in ATM gene causes ataxia telangiectasia revealed by whole-exome sequencing.

A Case of Ataxia-telangiectasia Presented With Hemophagocytic Syndrome.

Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis?

Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.

Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.

Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.

Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome.

T-cell prolymphocytic leukemia in an adolescent with ataxia-telangiectasia: novel approach with a JAK3 inhibitor (tofacitinib).

Long-term nutritional and gastrointestinal aspects in patients with ataxia telangiectasia.

Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms.

More than ataxia - Movement disorders in ataxia-telangiectasia.

Neurofibromatosis type-1 in a patient with ataxia-telangiectasia.

Characteristic Eye Movements in Ataxia-Telangiectasia-Like Disorder: An Explanatory Hypothesis.